*The following content is generated by AI and is for reference only.
Fmoc-L-4-Iodophenylalanine is a specialized F-protected amino acid derivative widely utilized in modern peptide synthesis and medicinal chemistry. With the chemical formula C18H17INO4 and CAS number 125609-35-8, this compound serves as a critical building block for constructing complex peptidomimetics and radiolabeled probes. The molecule features an L-phenylalanine backbone substituted with an iodine atom at the para-position of the phenyl ring, coupled with a fluorenylmethyloxycarbonyl (Fmoc) protecting group on the alpha-amino functionality. This specific structural arrangement allows researchers to introduce heavy atoms into peptide sequences without disrupting stereochemical integrity or biological activity during solid-phase peptide synthesis (SPPS).
The primary application of Fmoc-L-4-Iodophenylalanine lies in the development of diagnostic imaging agents and therapeutic peptides. Due to the presence of the iodine atom, this amino acid is frequently employed in radioiodination protocols to create high-specificity tracers for Single Photon Emission Computed Tomography (SPECT) or Positron Emission Tomography (PET) scans. It enables the precise labeling of biologically active peptides targeting specific receptors, such as somatostatin or glucagon-like peptide-1 receptors, facilitating non-invasive visualization of tumor metabolism and receptor distribution in vivo. Furthermore, the iodine substituent enhances lipophilicity and metabolic stability, making it valuable for optimizing the pharmacokinetic profiles of drug candidates.
In synthetic workflows, the Fmoc group ensures orthogonality, allowing selective deprotection under mild basic conditions while maintaining the integrity of other sensitive functional groups. This property streamlines the assembly of multi-segmented peptides required for advanced drug discovery programs. Researchers also leverage its unique mass signature in mass spectrometry for tracking peptide fragmentation patterns and verifying sequence accuracy. As a versatile reagent, Fmoc-L-4-Iodophenylalanine bridges the gap between organic synthesis and nuclear medicine, playing an indispensable role in advancing targeted therapies and molecular diagnostics. Its availability supports diverse research initiatives ranging from fundamental biochemistry to clinical translation, underscoring its status as a cornerstone material in contemporary pharmaceutical science.